Mishra Sanskriti, Shekunov Julia, Derscheid Della J, Canterbury Elizabeth A, Leung Jonathan G
Mayo Clinic, Rochester, MN, USA.
Case Rep Psychiatry. 2022 Mar 25;2022:2149301. doi: 10.1155/2022/2149301. eCollection 2022.
Guanfacine is a selective alpha-2a adrenoreceptor agonist that with overdose can cause symptoms ranging from mild sedation to coma, respiratory depression, hyporeflexia, hypotonia, bradycardia, and hypotension. Despite a well-defined and predictable toxidrome, variations can be seen based on multiple factors including age, quantity ingested, organ functions, coingestions, time since ingestion, and specific dosage form. Here, we describe two cases of delayed presentation of extended release guanfacine toxicity and highlight the variations encountered in the toxidrome presentation. These cases bring to attention the importance of maintaining a high suspicion for such atypical presentations, keeping in mind the limitations of managing these complications on an inpatient psychiatric unit.
胍法辛是一种选择性α-2a肾上腺素能受体激动剂,过量服用可导致从轻度镇静到昏迷、呼吸抑制、反射减退、肌张力减退、心动过缓和低血压等症状。尽管有明确且可预测的中毒综合征,但基于多种因素,包括年龄、摄入量、器官功能、合并摄入情况、摄入后的时间以及特定剂型,仍可观察到差异。在此,我们描述两例缓释胍法辛中毒延迟就诊的病例,并强调中毒综合征表现中遇到的差异。这些病例提醒人们要高度怀疑此类非典型表现,同时牢记在住院精神科病房处理这些并发症的局限性。